Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)

Condition:   OsteomalaciaIntervention:   Drug: OsteomalaciaSponsors:   National Institute of Dental and Craniofacial Research (NIDCR);   National Institutes of Health Clinical Center (CC)Recruiting - verified August 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials